AbbVie (NYSE: ABBV) is a pharmaceutical company. It is one of the most consistent names on the stock market and is a solid ...

Exelixis, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved CABOMETYX® (cabozantinib) for the treatment of 1) adult and pediatric patients 12 years of age and older ...

EUROPEAN shares bounced back on Wednesday following four sessions of declines on optimism around positive developments in the Ukraine-Russia conflict, while a cooler-than-expected US inflation report ...

Guest writer Danni Hewson breaks down the Magnificent Seven’s recent travails and the warning it provides for retail ...

We call it healthcare, but in reality, it is “disease care.” The current system is designed in such a way that you only become part of it when you fall sick. The moment you are labeled a "patient," ...

Senate Minority Leader Charles E. Schumer (D-New York) said on the Senate floor Wednesday that not enough Democrats support the Republican-led funding measure that passed the House on Tuesday. With ...

has a solid resume and focuses on medical-technology stocks. Meanwhile, well-credentialed managers Rebecca Sykes (who focuses on pharmaceutical names), Wen Shi (who concentrates on biotech stocks ...

He also denounced escalating blowback that Musk has received for his work for Trump, including slumping sales and stock prices at Tesla ... Trump administration to resume military aid to Ukraine and ...

Exclusive: U.S. piles pressure on Iraq to resume Kurdish oil exports ... to reciprocal tariffs that include the automobile and pharmaceutical industries. Reuters, the news and media division ...

The latest data Istat on the Italian industrial production They could rewrite the concept of Made in Italy. Some of ...